title: A systematic review of cooling for neuroprotection in neonates with hypoxic ischemic encephalopathy - are we there yet?
abstract: BACKGROUND
  The objective of this study was to systematically review randomized trials assessing therapeutic hypothermia as a treatment for term neonates with hypoxic ischemic encephalopathy.
  
  
  METHODS
  The Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CINAHL databases, reference lists of identified studies, and proceedings of the Pediatric Academic Societies were searched in July 2006. Randomized trials assessing the effect of therapeutic hypothermia by either selective head cooling or whole body cooling in term neonates were eligible for inclusion in the meta-analysis. The primary outcome was death or neurodevelopmental disability at >or= 18 months.
  
  
  RESULTS
  Five trials involving 552 neonates were included in the analysis. Cooling techniques and the definition and severity of neurodevelopmental disability differed between studies. Overall, there is evidence of a significant effect of therapeutic hypothermia on the primary composite outcome of death or disability (RR: 0.78, 95% CI: 0.66, 0.92, NNT: 8, 95% CI: 5, 20) as well as on the single outcomes of mortality (RR: 0.75, 95% CI: 0.59, 0.96) and neurodevelopmental disability at 18 to 22 months (RR: 0.72, 95% CI: 0.53, 0.98). Adverse effects include benign sinus bradycardia (RR: 7.42, 95% CI: 2.52, 21.87) and thrombocytopenia (RR: 1.47, 95% CI: 1.07, 2.03, NNH: 8) without deleterious consequences.
  
  
  CONCLUSIONS
  In general, therapeutic hypothermia seems to have a beneficial effect on the outcome of term neonates with moderate to severe hypoxic ischemic encephalopathy. Despite the methodological differences between trials, wide confidence intervals, and the lack of follow-up data beyond the second year of life, the consistency of the results is encouraging. Further research is necessary to minimize the uncertainty regarding efficacy and safety of any specific technique of cooling for any specific population.
authors.affiliation: Department of Neonatal Paediatrics, Women's and Children's Health Service, Perth, Australia. sven.schulzke@health.wa.gov.au
authors.forename: Sven M
authors.initials: SM
authors.lastname: Schulzke
authors.forename: Shripada
authors.initials: S
authors.lastname: Rao
authors.forename: Sanjay K
authors.initials: SK
authors.lastname: Patole
mesh_terms: D015984:Causality; D002490:Central Nervous System / Q000503:physiopathology*; D002547:Cerebral Palsy / Q000453:epidemiology; D002658:Developmental Disabilities / Q000453:epidemiology; D005500:Follow-Up Studies; D014943:Global Health; D006801:Humans; D007036:Hypothermia, Induced; D020925:Hypoxia-Ischemia, Brain / Q000401:mortality / Q000503:physiopathology* / Q000628:therapy*; D007223:Infant; D007231:Infant, Newborn; D016019:Survival Analysis; D016896:Treatment Outcome; D014786:Vision Disorders / Q000453:epidemiology